Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Precision BioSciences, Inc. - Common Stock
(NQ:
DTIL
)
7.270
-0.840 (-10.36%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 15, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Precision BioSciences, Inc. - Common Stock
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Precision BioSciences Receives U.S. Patent Allowance Covering PBGENE-PMM for m.3243-Associated Mitochondrial Diseases
September 27, 2023
From
Precision BioSciences, Inc.
Via
Business Wire
Why Femasys Shares Are Trading Higher By Over 200%; Here Are 20 Stocks Moving Premarket
↗
September 26, 2023
Gainers Femasys Inc. (NASDAQ: FEMY) shares rose 201% to $1.00 in pre-market trading after the company received FDA 510(k) clearance for FemaSeed, an infertility treatment.
Via
Benzinga
What 4 Analyst Ratings Have To Say About Precision BioSciences
↗
September 19, 2023
Via
Benzinga
Precision BioSciences Hosts Virtual R&D Day Highlighting its Proprietary ARCUS Technology and Recent In Vivo Gene Editing Program Developments
September 12, 2023
From
Precision BioSciences, Inc.
Via
Business Wire
The Latest Analyst Ratings for Precision BioSciences
↗
August 17, 2023
Via
Benzinga
A Preview Of Precision BioSciences's Earnings
↗
August 03, 2023
Via
Benzinga
Precision BioSciences to Attend and Present at Upcoming September Investor Conferences
September 06, 2023
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences to Host In Vivo Gene Editing R&D Day on September 12, 2023
August 31, 2023
From
Precision BioSciences, Inc.
Via
Business Wire
What Is Precision BioSciences CAR T Pipeline Value? Analyst Lowers Price Target To Justify Valuation
↗
August 17, 2023
Wednesday, Precision BioSciences Inc (NASDAQ: DTIL) announced the completion of a strategic transaction with Imugene Limited for global rights to Azercabtagene Zapreleucel (azer-cel), Precision's lead...
Via
Benzinga
Why Is Precision BioSciences Stock Soaring Today?
↗
August 16, 2023
Precision BioSciences Inc (NASDAQ: DTIL) announced the completion of a strategic transaction with Imugene Limited for global rights to Azercabtagene Zapreleucel (azer-cel), Precision's lead allogeneic...
Via
Benzinga
Preview: Precision BioSciences's Earnings
↗
May 08, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
August 16, 2023
Via
Benzinga
Why DLocal Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket
↗
August 16, 2023
Gainers
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
↗
August 16, 2023
Investors will want to get ready for another busy day of trading as we cover the biggest pre-market stock movers for Wednesday!
Via
InvestorPlace
Precision BioSciences Completes Strategic Transaction with Imugene for Azer-Cel in Cancer
August 15, 2023
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Reports Second Quarter 2023 Financial Results and Provides Business Update
August 04, 2023
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences to Report Second Quarter Results on August 4, 2023
August 01, 2023
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Provides Updates on Azer-Cel FDA Meeting, Potential Partnerships and Timing of In Vivo R&D Day
July 27, 2023
From
Precision BioSciences, Inc.
Via
Business Wire
Earnings Scheduled For August 4, 2023
↗
August 04, 2023
Companies Reporting Before The Bell • WPP (NYSE:WPP) is projected to report earnings for its first quarter. • Anglogold Ashanti (NYSE:AU) is likely to report earnings for its first quarter.
Via
Benzinga
3 Penny Stocks to Catapult You Into the Millionaires’ Club
↗
July 13, 2023
These penny stocks can deliver tremendous upside from their depressed range. Wall Street analysts can back it up!
Via
InvestorPlace
Precision BioSciences Announces Oral Presentation of Positive ARCUS® Gene Editing Data at International Liver Congress 2023
June 22, 2023
From
Precision BioSciences, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Wednesday
↗
June 14, 2023
On Wednesday, 33 stocks hit new 52-week lows.
Via
Benzinga
Precision BioSciences to Present at Upcoming June Investor Conferences
June 05, 2023
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Provides Update on Allogeneic CAR T Programs and Regulatory Path Forward
May 31, 2023
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences to Provide an Update on its Allogeneic CAR T Programs via Hosted Virtual Webcast and Conference Call on May 31, 2023
May 25, 2023
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences to Participate in Upcoming Stifel Genetic Medicines Day
May 24, 2023
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Presents Preclinical Data Demonstrating Potential of ARCUS for Treatment of Duchenne Muscular Dystrophy at the American Society of Gene & Cell Therapy 26th Annual Meeting
May 19, 2023
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Announces Publication of its Preclinical In Vivo Gene Editing Abstract on Duchenne Muscular Dystrophy Program for the American Society of Gene & Cell Therapy 26th Annual Meeting
May 12, 2023
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Reports First Quarter 2023 Financial Results and Provides Business Update
May 09, 2023
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
May 08, 2023
From
Precision BioSciences, Inc.
Via
Business Wire
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
